DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



AURORA: Crestor 10mg vs Placebo in Subjects With ESRD

Information source: AstraZeneca
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: End Stage Renal Failure

Intervention: 10mg Rosuvastatin (Drug)

Phase: Phase 3

Status: Active, not recruiting

Sponsored by: AstraZeneca

Official(s) and/or principal investigator(s):
AstraZeneca Crestor Medical Sciences Director, MD, Study Director, Affiliation: AstraZeneca

Summary

The purpose of this study is to see if rosuvastatin helps to reduce the number of heart attacks, strokes and cardiovascular deaths in patients undergoing haemodialysis.

Clinical Details

Official title: A Study to Evaluate the Use of Rosuvastatin in Subjects On Regular Haemodialysis: an Assessment of Survival and Cardiovascular Events (AURORA). A Double Blind, Randomised, Phase 3b, Parallel-Group Study to Compare the Effects of Rosuvastatin With Placebo on Assessment of Survival & Cardiovascular Events When Given to Subjects With End-Stage Renal Failure on Chronic Haemodialysis Treatment

Study design: Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Assessment of time to major cardiovascular event (combined endpoint of non-fatal stroke, non-fatal myocardial infarction or cardiovascular death).

Secondary outcome:

To assess the safety of treatment

To determine the cost due to hospitalisations (expressed as cost per life year saved)

To determine the effect of treatment on the % changes in various cholesterol laboratory assessments

Eligibility

Minimum age: 50 Years. Maximum age: 80 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Male or female subjects with end-stage renal failure aged 50-80 years, who have

received regular haemodialysis treatment for at least 3 months

Exclusion Criteria:

- Subjects will have no underlying condition that is expected to limit survival to less

than 1 year and is also unrelated to end-stage renal disease (ESRD). Subjects should not have received a statin therapy within the past 6 months

Locations and Contacts

Research Site, Bregenz, Austria

Research Site, Feldkirch-Tisis, Austria

Research Site, Graz, Austria

Research Site, Innsbruck, Austria

Research Site, Linz, Austria

Research Site, St. Poelten, Austria

Research Site, Wels, Austria

Research Site, Wien, Austria

Research Site, Aalst, Belgium

Research Site, Antwerpen, Belgium

Research Site, Brussels, Belgium

Research Site, La Louviere, Belgium

Research Site, Leuven, Belgium

Research Site, Liège, Belgium

Research Site, Sofia, Bulgaria

Research Site, Pleven, Bulgaria

Research Site, Plovdiv, Bulgaria

Research Site, Kitchener, Canada

Research Site, Rosemount, Canada

Research Site, HRADEC KRALOVE, Czech Republic

Research Site, Liberec, Czech Republic

Research Site, Pardubice, Czech Republic

Research Site, Praha 2, Czech Republic

Research Site, Praha 4, Czech Republic

Research Site, Praha 6, Czech Republic

Research Site, Tabor, Czech Republic

Research Site, Usti nad Labem, Czech Republic

Research Site, Hodonin, Czech Republic

Research Site, Fredericia, Denmark

Research Site, Frederiksberg, Denmark

Research Site, Herlev, Denmark

Research Site, Holbaek, Denmark

Research Site, Horsens, Denmark

Research Site, København Ø, Denmark

Research Site, Roskilde, Denmark

Research Site, Rønne, Denmark

Research Site, Slagelse, Denmark

Research Site, Sønderborg, Denmark

Research Site, Viborg, Denmark

Research Site, Hyvinkaa, Finland

Research Site, Joensuu, Finland

Research Site, Lahti, Finland

Research Site, Kotka, Finland

Research Site, Kuopio, Finland

Research Site, Oulu, Finland

Research Site, Pori, Finland

Research Site, Tammisaari, Finland

Research Site, Tampere, Finland

Research Site, Turku, Finland

Research Site, Helsinki, Finland

Research Site, AMIENS, France

Research Site, ANNONAY CEDEX, France

Research Site, AUBERVILLIERS, France

Research Site, BEAUVAIS, France

Research Site, BETHUNE CEDEX, France

Research Site, BOULOGNE SUR MER, France

Research Site, CHAMBERY, France

Research Site, CHAMPIGNY SUR MARNE, France

Research Site, COLMAR CEDEX, France

Research Site, CREIL CEDEX 1, France

Research Site, EVREUX CEDEX, France

Research Site, FLEURY MEROGIS, France

Research Site, FOIX CEDEX, France

Research Site, Le Kremlin-Bicetre, France

Research Site, MAUBEUGE, France

Research Site, MEAUX, France

Research Site, MONTBONNOT SAINT MARTIN, France

Research Site, MONT DE MARSAN CEDEX, France

Research Site, NIMES, France

Research Site, OLIVET, France

Research Site, PARIS, France

Research Site, QUIMPER CEDEX, France

Research Site, SAINT MAURICE, France

Research Site, SAINT MICHEL, France

Research Site, TOURNAN EN BRIE, France

Research Site, VALENCIENNES CEDEX, France

Research Site, VANDOEUVRE LES NANCY, France

Research Site, VICHY, France

Research Site, Freiburg, Germany

Research Site, Ansbach, Germany

Research Site, Erlangen, Germany

Research Site, München, Germany

Research Site, Frankfurt, Germany

Research Site, Greifswald, Germany

Research Site, Rostock, Germany

Research Site, Bad Münder, Germany

Research Site, Hann Münden, Germany

Research Site, Aschaffenburg, Germany

Research Site, Düsseldorf, Germany

Research Site, Saarbrucken, Germany

Research Site, Berlin, Germany

Research Site, Bischofswerda, Germany

Research Site, Dresden, Germany

Research Site, Duisburg, Germany

Research Site, Ingolstadt, Germany

Research Site, Jena, Germany

Research Site, Kaufbeuren, Germany

Research Site, Luedenscheid, Germany

Research Site, Marktheidenfeld, Germany

Research Site, Pfarrkirchen, Germany

Research Site, Pirmasens, Germany

Research Site, Regensburg, Germany

Research Site, Tangermünde, Germany

Research Site, Waldshut, Germany

Research Site, Alexandroupoli, Greece

Research Site, Athens, Greece

Research Site, Ioannina, Greece

Research Site, Thessaloniki, Greece

Research Site, Veroia, Greece

Research Site, Budapest, Hungary

Research Site, Gyor, Hungary

Research Site, Miskolc, Hungary

Research Site, Nyiregyhaza, Hungary

Research Site, Szeged, Hungary

Research Site, Székesfehérvár, Hungary

Research Site, Veszprém, Hungary

Research Site, Reykjavik, Iceland

Research Site, Galway, Ireland

Research Site, Distrito Federal, Mexico

Research Site, San Luis Potosi, Mexico

Research Site, ALKMAAR, Netherlands

Research Site, ALMELO, Netherlands

Research Site, AMERSFOORT, Netherlands

Research Site, Amsterdam, Netherlands

Research Site, ARNHEM, Netherlands

Research Site, DEN BOSCH, Netherlands

Research Site, DEN HAAG, Netherlands

Research Site, DEVENTER, Netherlands

Research Site, DORDRECHT, Netherlands

Research Site, EMMEN, Netherlands

Research Site, GRONINGEN, Netherlands

Research Site, LEEUWARDEN, Netherlands

Research Site, NIEUWEGEIN, Netherlands

Research Site, ROTTERDAM, Netherlands

Research Site, SITTARD, Netherlands

Research Site, TILBURG, Netherlands

Research Site, Bergen, Norway

Research Site, Drammen, Norway

Research Site, FREDRIKSTAD, Norway

Research Site, Lillehammer, Norway

Research Site, Oslo, Norway

Research Site, Skien, Norway

Research Site, STAVANGER, Norway

Research Site, Tønsberg, Norway

Research Site, Trondheim, Norway

Research Site, Lorenskog, Norway

Research Site, Bialystok, Poland

Research Site, Gdansk, Poland

Research Site, Katowice, Poland

Research Site, Kraków, Poland

Research Site, Lublin, Poland

Research Site, Opole, Poland

Research Site, Plock, Poland

Research Site, Rybnik, Poland

Research Site, Wloclawek, Poland

Research Site, EKSJÖ, Sweden

Research Site, Eskilstuna, Sweden

Research Site, Falun, Sweden

Research Site, GÄVLE, Sweden

Research Site, Göteborg, Sweden

Research Site, JÖNKÖPING, Sweden

Research Site, Karlstad, Sweden

Research Site, Linköping, Sweden

Research Site, Lund, Sweden

Research Site, Mölndal, Sweden

Research Site, NORRKÖPING, Sweden

Research Site, Örebro, Sweden

Research Site, Skövde, Sweden

Research Site, Stockholm, Sweden

Research Site, Trollhättan, Sweden

Research Site, Uppsala, Sweden

Research Site, Aarau, Switzerland

Research Site, Bern, Switzerland

Research Site, Geneve, Switzerland

Research Site, Lausanne, Switzerland

Research Site, St. Gallen, Switzerland

Research Site, Zürich, Switzerland

Research Site, Kilmarnock, United Kingdom

Research Site, Dumfries, United Kingdom

Research Site, Bradford, United Kingdom

Research Site, Dundee, United Kingdom

Research Site, Glasgow, United Kingdom

Research Site, Hull, United Kingdom

Research Site, Leeds, United Kingdom

Research Site, London, United Kingdom

Research Site, Manchester, United Kingdom

Research Site, Middlesborough, United Kingdom

Research Site, Newcastle, United Kingdom

Research Site, Plymouth, United Kingdom

Research Site, Rhyl, United Kingdom

Research Site, Sheffield, United Kingdom

Research Site, Surrey, United Kingdom

Research Site, Calgary, Alberta, Canada

Research Site, Edmonton, Alberta, Canada

Research Site, Lethbridge, Alberta, Canada

Research Site, Istanbul, Altunizade, Turkey

Research Site, Cebeci, Ankara, Turkey

Research Site, Kampus, Antalya, Turkey

Research Site, Antalya, Arapsuyu, Turkey

Research Site, Bergamo, BG, Italy

Research Site, Treviglio, BG, Italy

Research Site, Ankara, Besevler, Turkey

Research Site, Izmir, Bornova, Turkey

Research Site, Kelowna, British Columbia, Canada

Research Site, Vancouver, British Columbia, Canada

Research Site, CREMONA, CR, Italy

Research Site, Mexico, D.F., Mexico

Research Site, Genova, GE, Italy

Research Site, Bursa, Gorukle, Turkey

Research Site, Acapulco, Guerrero, Mexico

Research Site, Istanbul, Haydarpasa, Turkey

Research Site, Guadalajara, Jalisco, Mexico

Research Site, Seongnam-Si, Korea, Korea, Republic of

Research Site, Seoul, Korea, Korea, Republic of

Research Site, Lodi, LO, Italy

Research Site, Rozzano, MI, Italy

Research Site, Winnipeg, Manitoba, Canada

Research Site, Milano, Mi, Italy

Research Site, Cuernavaca, Morelos, Mexico

Research Site, Saint John, New Brunswick, Canada

Research Site, St Leonards, New South Wales, Australia

Research Site, Antrim, Northern Ireland, United Kingdom

Research Site, Belfast, Northern Ireland, United Kingdom

Research Site, Newry, Northern Ireland, United Kingdom

Research Site, Omagh, Northern Ireland, United Kingdom

Research Site, Halifax, Nova Scotia, Canada

Research Site, Monterrey, Nuevo Leon, Mexico

Research Site, London, Ontario, Canada

Research Site, Mississauga, Ontario, Canada

Research Site, Scarborough, Ontario, Canada

Research Site, Toronto, Ontario, Canada

Research Site, York, Ontario, Canada

Research Site, Curitiba, PR, Brazil

Research Site, Greenfield Park, Quebec, Canada

Research Site, Montreal, Quebec, Canada

Research Site, Laval, Quebec, Canada

Research Site, Trois-Rivieres, Quebec, Canada

Research Site, Herston, Queensland, Australia

Research Site, REGGIO CALABRIA, RC, Italy

Research Site, Sao Paulo, SP, Brazil

Research Site, Busto Arsizio, VA, Italy

Additional Information

Starting date: July 2004
Last updated: October 5, 2006

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009